Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
Division of Oncology and the Dr Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel.
S
S
Paluch-Shimon
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
F
F
Cardoso
Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
C
C
Sessa
Vall d`Hebron University Hospital Institut d'Oncologia, Barcelona, Spain.
J
J
Balmana
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
M J
MJ
Cardoso
School of Clinical Medicine, University of Cambridge, Cambridge, UK.
F
F
Gilbert
Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
E
E
Senkus
D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control*; D055088:Early Detection of Cancer; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D009154:Mutation; D009386:Neoplastic Syndromes, Hereditary; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control*